Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in Metastatic and Locally Advanced Angiosarcoma
NCT02048722Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jun 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in angiosarcoma, sponsored by Northwestern University. Started Jun 2014; status: completed.
02
Drugs
regorafenib
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on NCT02048722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048722.